Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Onsite Women’s Health, a leading national provider of breast health services, today announced the launch of …
